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Four strains of an unknown coryneform bacterium were isolated in pure culture from females with urinary
tract infections. Strong urease activity and the ability to slowly ferment maltose but not glucose were the most
significant phenotypic features of this catalase-positive, nonmotile, nonlipophilic, rod-shaped bacterium which
served to distinguish it from all other presently defined coryneform bacteria. Chemotaxonomic investigations
demonstrated that the unknown bacterium belonged to the genus Corynebacterium. Comparative 16S rRNA
gene sequence analysis revealed that the isolates were genealogically identical and represented a new subline
within the genus Corynebacterium, for which the designation Corynebacterium riegelii sp. nov. is proposed. The
type strain of Corynebacterium riegelii is CCUG 38180 (DSM 44326, CIP 105310).
For many years, the pathogenic potential of coryneform bac-
teria other than Corynebacterium diphtheriae has been grossly
underestimated. It is only in the last decade that both clinical
microbiologists and physicians became more appreciative both
of the pathogenic potential of coryneform bacteria and of the
great diversity of coryneform bacteria associated with human
disease. This growing awareness, at least in part, stems from
the implementation of more sophisticated schemes for the
identification of coryneform bacteria, exploiting biochemical,
chemotaxonomic, and molecular genetic methods. The appli-
cation of such polyphasic approaches has led to the description
of a plethora of new taxa of coryneform bacteria within recent
years, and for some of them a clear disease association could
be demonstrated (9). During an ongoing study on the differ-
entiation of clinically significant coryneform bacteria isolated
from human clinical specimens, workers in the Department of
Medical Microbiology at the University of Zürich (DMMZ)
isolated four strains from the urine of females with urinary
tract infections. These isolates could not be assigned to any of
the established taxa of coryneform bacteria. Therefore, we
decided to study these four strains further using a polyphasic
taxonomic approach including both phenotypic and molecular
genetic methods. On the basis of the results of this investiga-
tion we propose a new Corynebacterium species, Corynebacte-
rium riegelii sp. nov., for the strains associated with urinary
tract infections in females.
MATERIALS AND METHODS
Strains and culture conditions. Strains DMMZ 2415 (Culture Collection of
the University of Göteborg [CCUG], Göteborg, Sweden; CCUG 38180), DMMZ
2582 (CCUG 38181), DMMZ 3128 (CCUG 38182), and DMMZ 3240 (CCUG
38242) were included in this study and were primarily isolated from dip-slide
cystine-lactose-electrolyte-deficient agar (Orion Diagnostics, Espoo, Finland).
All strains were subcultured on Columbia agar plates (Difco Laboratories, De-
troit, Mich.) supplemented with 5% sheep blood for 24 h at 37°C in a 5% CO2
atmosphere. Staphylococcus aureus ATCC 25923 was used for analysis of the
CAMP reaction.
Biochemical profiles. The methods used for determination of the biochemical
profiles have been described previously (7). API Coryne strips were read after
48 h, and API 50CH reactions performed with the 50 CHE medium (all from
bioMérieux, Marcy l’Etoile, France) were read after 120 h of incubation at 37°C
in ambient air.
Antimicrobial agent susceptibility patterns. The MICs of 13 antimicrobial
agents were determined with the Merlin Micronaut system (Merlin Diagnostics,
Bornheim-Hersel, Germany) as outlined previously (5). MICs were interpreted
according to the criteria for staphylococci established by the National Committee
for Clinical Laboratory Standards (NCCLS) (12), although it is emphasized that
NCCLS has not explicitly published criteria for coryneform bacteria.
Chemotaxonomic investigations. Cellular fatty acid (CFA) patterns were de-
termined with the Sherlock system (Microbial ID, Inc., Newark, Del.) as outlined
previously (18). Techniques used for analyses of whole-cell hydrolysates for the
presence of meso-diaminopimelic acid and mycolic acids were as described be-
fore (7).
Molecular genetic investigations. A large fragment (ca. 1,500 bases) of the 16S
rRNA genes of strains DMMZ 2415, DMMZ 2582, and DMMZ 3128 was
amplified by PCR by using universal primers pA and pH* as described previously
(11). The PCR products were purified by using a Prep-A-Gene kit (Bio-Rad,
Hercules, Calif.) and were sequenced by using a Taq DyeDeoxy terminator cycle
sequencing kit (Applied Biosystems, Inc., Foster City, Calif.) and a model 373A
automatic sequencer (Applied Biosystems). The sequences determined were
aligned with those of reference organisms (i.e., other actinomycetes with high
G1C contents) obtained from the European Molecular Biology Laboratory
(EMBL) Data Library by using the program PILEUP (3), and the alignment was
corrected manually. An unrooted phylogenetic tree was constructed by using the
neighbor-joining method (14). The stability of relationships was assessed by using
the programs SEQBOOT, DNADIST, NEIGHBOR, and CONSENSE of the
PHYLIP package (4).
Nucleotide sequence accession number. The nucleotide sequence of the 16S
rRNA of strain DMMZ 2415T (CCUG 38180T) has been deposited in the EMBL
Data Library under accession no. Y14651.
RESULTS AND DISCUSSION
The four strains of coryneform bacteria were isolated in
quantities of .105 CFU/ml from the urine of symptomatic
female patients (between 21 and 62 years of age) with no
underlying diseases. The unknown coryneforms grew in pure
culture, and between 5 and 10 leukocytes/mm3 were seen on
direct examination of the urine. Erythrocytes and proteins
were not elevated, and crystals were not seen. There was no
indication that the four outpatients were epidemiologically
linked; the isolates had been recovered over a 1-year period,
from August 1996 to July 1997.
All four strains grew as whitish, glistening, convex colonies
with entire edges of up to 1.5 mm in diameter after 48 h of
incubation. All strains were nonlipophilic. Two strains were of
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a creamy consistency, while the others exhibited a slightly
sticky consistency. Gram stains showed typical club-shaped
coryneform bacteria (indicative of true Corynebacterium spp.)
of 1 to 3 mm in length, and they were arranged as single cells,
in pairs, or in small clusters. The organisms were not partially
acid fast.
The biochemical screening reactions of the four isolates by
the scheme of von Graevenitz and Funke (17) were as follows:
catalase positive; weak fermentative metabolism and weak an-
aerobic growth; nonmotile; nitrate reduction negative; strong
urease activity (i.e., positive within 5 min in Christensen’s urea
broth); esculin hydrolysis negative; CAMP reaction negative;
and slow acid production from maltose (and ribose) but not
from sucrose, mannitol, or xylose. Surprisingly, no acid forma-
tion from glucose was observed either in cystine Trypticase
agar medium or in the API Coryne gallery (the corresponding
numerical profiles were 0101224, 2001224, and 2101224 [two
times]) and the API 50CH gallery. The authors are not aware
of any other taxon belonging to the coryneform bacteria which
produces acid from maltose but not from glucose. It was evi-
dent that the unknown coryneforms exhibited a biochemical
pattern that was distinct from those of all other presently
defined nonlipophilic, fermentative corynebacteria (Table 1).
The unknown coryneform bacterium could be differentiated
from the urea-splitting strains C. glucuronolyticum, C. pseudo-
tuberculosis, and C. ulcerans by its negative CAMP reaction
and from C. amycolatum by the unknown bacterium’s posses-
sion of mycolic acids (see below). All these other urea-splitting
Corynebacterium species, however, also produce acid from glu-
cose. Further testing of the enzymatic activities of the unknown
bacterium revealed the presence of esterase (C4), esterase
lipase (C8), leucine arylamidase, and cystine arylamidase.
Determination of the MICs of various antimicrobial sub-
stances revealed that all four strains were susceptible to ceph-
alothin (MIC, #0.125 mg/ml), chloramphenicol (MIC range,
1 to 4 mg/ml), ciprofloxacin (MIC, 0.125 mg/ml), fusidic acid
(MIC, 0.03125 mg/ml), gentamicin (MIC range, 0.125 to 0.25
mg/ml), penicillin (MIC range, 0.0625 to 0.125 mg/ml), rifampin
(MIC, #0.02 mg/ml), tetracycline (MIC range, 1 to 2 mg/ml),
and vancomycin (MIC, 0.5 mg/ml) but were resistant to cefe-
tamet (MIC range, 64 to .64 mg/ml), ceftibuten (MIC, 32 mg/
ml), and fosfomycin (MIC, .256 mg/ml). The MICs of oxacillin
were 1 to 4 mg/ml. Overall, the antimicrobial susceptibility
patterns of the four unknown strains corresponded to those of
most other nonlipophilic corynebacteria (9).
Chemotaxonomic investigations revealed that C16:0 (range,
48 to 56% of all CFAs), C18:1v9c (range, 24 to 33%), and C18:0
(range, 7 to 11%) were the predominant CFAs, which was
compatible with the assignment of the four strains to the genus
Corynebacterium (1, 18). Additionally, thin-layer chromato-
graphic analysis demonstrated meso-diaminopimelic acid as
the cell wall diamino acid and the presence of short-chain
mycolic acids, thereby confirming the identities of the isolates
as members of the genus Corynebacterium.
To determine the phylogenetic relatedness of the strains,
their 16S rRNA genes were amplified by PCR and were sub-
jected to sequence analysis. The almost complete 16S rRNA
gene sequence (1,415 nucleotides) of strain DMMZ 2415 and
partial 16S rRNA gene sequences of strains DMMZ 2582 and
DMMZ 3128 (approximately 800 nucleotides) were deter-
mined. Comparative sequence analysis revealed no nucleotide
differences between the isolates (100% sequence similarity),
thereby demonstrating their genealogical homogeneity. Se-
quence searches of EMBL/GenBank libraries with the FASTA
program revealed that the newly determined sequences were
most closely related to those of the species of the genus
Corynebacterium (16S rRNA sequence similarities, .92%; Ta-
ble 2). Significantly lower levels of relatedness were shown with
other gram-positive bacteria with high G1C contents (data not
shown). A tree depicting the phylogenetic relationships of the
unidentified bacterium (as exemplified by strain DMMZ 2415)
within the genus Corynebacterium is presented in Fig. 1. The
new bacterium showed a close phylogenetic affinity to the sub-
cluster of species embracing “C. pseudogenitalium,” “C. geni-
talium,” C. imitans, C. coyleae, C. mucifaciens, C. afermentans,
C. auris, C. mycetoides, and C. lipophiloflavum. It is evident
from both sequence divergence values and the phylogenetic
analysis that the unknown bacterium is not specifically related
to any other species and that the .3% 16S rRNA sequence
divergence unequivocally demonstrates that the bacterium rep-
resents a new Corynebacterium species (15).
We explain that the Corynebacterium species described in
this report has not been reported in the literature before by the
fact that coryneform bacteria from urine samples, even when
growing in pure cultures, were considered contaminants and
were not further identified by many clinical laboratories for
TABLE 1. Characteristics which differentiate C. riegelii from other fermenting, nonlipophilic Corynebacterium spp.
















C. riegelii 2 1 2 V V 2 (1) 2 2
C. amycolatum V V 2 1 1 1 V V 2 Mycolic acid negative
C. argentoratense 2 2 2 1 V 1 2 2 2 Chymotrypsin positive
C. coyleae 2 2 2 1 1 (1) 2 2 1
C. diphtheriae V 2 2 2 2 1 1 2 2 Cystinase positive
C. glucuronolyticum V V V 1 V 1 V 1 1 b-Glucuronidase positive
C. imitans 2 2 2 W 1 1 1 W 1 Tyrosine negative
C. matruchotii 1 2 V 1 2 1 1 1 2 “Whip handle” (Gram stain)
C. minutissimum 2 2 2 1 1 1 1 V 2 Tyrosine positive
C. pseudotuberculosis 2 1 2 2 V 1 1 V REV Glycogen negative
C. striatum 1 2 2 1 1 1 2 V V Tyrosine positive
C. ulcerans 2 1 2 2 1 1 1 2 REV Glycogen positive
C. xerosis V 2 2 1 1 1 1 1 2 Yellowish
a Data are from previous reports (2, 6, 8, 9). Abbreviations and symbols: 2, negative reaction; 1, positive reaction; V, variable reaction; parentheses, delayed reaction;
W, weak reaction; REV, reverse CAMP reaction.
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many years. However, as has been demonstrated for C. urea-
lyticum (9), true corynebacteria may cause urinary tract infec-
tions. Our data indicate that the newly described Corynebacte-
rium may not be recovered from patients with urinary tract
infections as often as C. urealyticum is (four patients with
infections caused by the newly described bacterium versus nine
patients with C. urealyticum infections diagnosed by DMMZ
during a 12-month period from August 1996 to July 1997).
C. urealyticum and the new Corynebacterium both exhibit
strong urease activity, which has been demonstrated as a
pathogenicity factor for C. urealyticum as well as for other
genitourinary bacterial pathogens (e.g., Proteus mirabilis) and
which may also be the case for the new Corynebacterium.
Only a very few prokaryotes (e.g., Ruminobacter amylophilus
[16]) have been reported to produce acid from maltose (which
is composed of two glucose molecules) but not from glucose.
Although it is not the purpose of this paper to address the
mechanism responsible for this observation, it seems not un-
likely that the new Corynebacterium species contains an ATP
binding cassette transporter system for maltose uptake (10) but
lacks a glucose phosphotransferase system for glucose uptake
(13). However, irrespective of the precise mechanism, it is
important to reemphasize that to our knowledge the newly
described Corynebacterium species is the only coryneform bac-
terium known to date to possess this physiological attribute,
thereby making it easily recognizable in the routine laboratory.
It is obvious that the new Corynebacterium is probably a
rarely encountered microorganism, but it is most likely that
other clinical microbiologists will also recognize it once it has
been described. We therefore emphasize the importance of
identifying coryneform bacteria to the species level whenever
those are recovered in pure culture from clinical specimens (9).
On the basis of the results of the phenotypic and molecular
genetic findings, we propose that the unknown coryneform
bacterium described above be classified as a new species of the
genus Corynebacterium, for which the name Corynebacterium
riegelii sp. nov. is proposed.
C. riegelii sp. nov. Corynebacterium riegelii (rie.gel9ii. N.L.
gen. n. riegelii, of Riegel, to honor contemporary French mi-
crobiologist Philippe Riegel for his contributions to the taxon-
omy of the genus Corynebacterium as well as to the clinical
microbiology of coryneform bacteria). The description of the
characteristics given below is based on the results of studies
with the four strains.
Cells are gram positive, non-spore forming, and nonmotile.
They are typically club-shaped rods which appear as single
TABLE 2. Levels of 16S rRNA sequence similarity between
C. riegelii sp. nov. and other Corynebacterium species
Species (EMBL accession no.)a
% 16S rRNA se-
quence similarity with
C. riegelii sp. nov.
C. accolens (X80500) ............................................................. 94.7
“C. acetoacidophilum” (X84240).......................................... 93.1
C. afermentans subsp. afermentans (X82054) ..................... 96.4
C. ammoniagenes (X84440) .................................................. 94.0
C. amycolatum (X84244)....................................................... 94.7
C. argentoratense (X83955) ................................................... 94.6
C. auris (X82493) ................................................................... 95.5
C. bovis (X84444)................................................................... 92.5
C. callunae (X84251) ............................................................. 93.3
“C. camporrealensis” (Y09569)............................................. 93.2
C. coyleae (X96497) ............................................................... 96.9
C. cystitidis (X84252) ............................................................. 93.3
C. diphtheriae (X84248)......................................................... 94.6
“C. fastidiosum” (X84245) .................................................... 94.1
C. flavescens (X84441)........................................................... 93.5
“C. genitalium” (X84253) ...................................................... 96.9
C. glucuronolyticum (X86688)............................................... 92.1
C. glutamicum (X84257) ....................................................... 92.9
C. imitans (Y09044) ............................................................... 96.0
C. jeikeium (X84250) ............................................................. 93.9
C. kutscheri (X81871) ............................................................ 94.2
C. lipophiloflavum (Y09045) ................................................. 96.3
C. macginleyi (X80499).......................................................... 94.6
C. mastitidis (Y09806) ........................................................... 93.7
C. matruchotii (X84443) ........................................................ 93.6
C. minutissimum (X84678).................................................... 94.5
C. mucifaciens (Y11200) ....................................................... 96.4
C. mycetoides (X84241) ......................................................... 95.9
C. pilosum (X84246) .............................................................. 94.0
C. propinquum (X84438)....................................................... 94.2
C. pseudodiphtheriticum (X84258) ....................................... 94.0
“C. pseudogenitalium” (X81872) .......................................... 96.4
C. pseudotuberculosis (X84255) ............................................ 94.3
C. renale (X84249) ................................................................. 94.7
“C. segmentosum” (X84437) ................................................. 94.0
C. striatum (X84442).............................................................. 93.9
“C. tuberculostearicum” (X84247) ........................................ 94.1
C. ulcerans (X84256) ............................................................. 94.2
C. urealyticum (X84439)........................................................ 93.4
C. variabilis (X53185) ............................................................ 93.6
C. vitarumen (X84680) .......................................................... 93.8
C. xerosis (X84446) ................................................................ 94.0
a The numbers in parentheses are EMBL 16S rRNA nucleotide sequence
accession numbers.
FIG. 1. Unrooted tree showing the phylogenetic relationships of C. riegelii sp.
nov. and other members of the genus Corynebacterium. The tree, constructed by
using the neighbor-joining method, was based on a comparison of approximately
1,320 nucleotides. Bootstrap values, expressed as percentages of 500 replications,
are given at the branch points. EMBL sequence accession numbers are given in
parentheses.
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cells, in pairs, or in small clusters. Colonies are whitish, circular
with entire edges, convex, glistening, of up to 1.5 mm in diam-
eter after 48 h of incubation, and of a creamy or a slightly sticky
consistency. They have weak anaerobic growth. The organism
is catalase positive. Acid is produced from maltose, ribose,
trehalose, D-tagatose, and 5-ketogluconate, but acid is not
produced from glucose, sucrose, mannitol, xylose, glycerol,
erythritol, arabinose, adonitol, b-methylxyloside, galactose,
D-fructose, D-mannose, L-sorbose, rhamnose, dulcitol, inositol,
sorbitol, a-methyl-D-mannoside, a-methyl-D-glucoside, N-ace-
tylglucosamine, amygdalin, arbutin, salicin, cellobiose, lactose,
melibiose, inulin, melezitose, D-raffinose, amidon, glycogen,
xylitol, b-gentiobiose, D-turanose, D-lyxose, fucose, arabitol,
gluconate, or 2-ketogluconate. Nitrate is not reduced. Urea
hydrolysis is strongly positive. Esculin is not hydrolyzed. The
CAMP reaction is negative. The activities of esterase (C4),
esterase lipase (C8), leucine arylamidase, and cystine arylami-
dase are detected, whereas the activities of pyrazinamidase and
alkaline, as well as that of acid phosphatase, are variable. The
activities of pyrrolidonylarylamidase, lipase (C14), valine aryl-
amidase, trypsin, chymotrypsin, a-galactosidase, b-galactosi-
dase, b-glucuronidase, a-glucosidase, b-glucosidase, N-acetyl-
b-glucosaminidase, a-mannosidase, and a-fucosidase are not
detected.
The cell wall contains meso-diaminopimelic acid. Mycolic
acids are present. The main straight-chain saturated fatty acids
are palmitic and stearic acids; oleic acid is the predominant
unsaturated fatty acid. The organism is isolated from human
clinical specimens. The type strain, strain DMMZ 2415, has
been deposited in CCUG as strain CCUG 38180, in the Ger-
man Collection of Microorganisms and Cell Cultures, Braun-
schweig, Germany, as strain DSM 44326, and in the Collection
of the Institute Pasteur, Paris, France, as strain CIP 105310. It
has the features described above except that the activity of
alkaline phosphatase but not that of pyrazinamidase or acid
phosphatase is detected.
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